on SARTORIUS AG (isin : DE0007165631)
Sartorius Publishes 2025 Annual Report
Sartorius, a prominent player in the life sciences sector, has released its Annual Report for 2025. The report reveals the company's extensive engagement in biopharmaceutical research and manufacturing. Based in Göttingen, Germany, Sartorius supports the industry through its Lab Products & Services and Bioprocess Solutions divisions.
In 2025, Sartorius achieved a sales revenue of approximately 3.5 billion euros, demonstrating its significant role in global biotech drug production. The company operates in around 60 locations worldwide and employs over 14,000 people. Sartorius continues to enrich its offerings with strategic acquisitions, focusing on innovative solutions and technologies.
The company's financial calendar for 2026 includes key dates such as the Annual General Meeting on March 26 and multiple quarter results releases throughout the year.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS AG news